Here is a typical introduction, disclosures and disclaimers in clinical practice guidelines.
Urinary Tract Infection (UTI) continues to be among the top five reasons for consultations in health facilities nationwide. With the progressive development of new diagnostic and treatment modalities, patients are exposed to wide variations in clinical care and to potentially irrational and expensive health care practices. The use of clinical practice guidelines (CPGs) can potentially minimize practice variations and irrational management decisions by providing systematically formulated management recommendations derived from a critical review of existing literature.
In updating the guideline, the model of Shekelle  was followed wherein new evidence was assessed not only in terms of validity but also in the context of patient values, available health resources and improvements in current performance.
Lastly, this update aims to provide health care providers with updated evidence-based recommendations on the rational diagnosis and management of UTI in adults. These guidelines however cannot encompass all scenarios and under no circumstances should it replace sound clinical judgment of the physician.
I underlined what impressed me most.
I especially like the statement: “new evidence was assessed not only in terms of validity but also in the context of patient values, available health resources and improvements in current performance.
This reminds me of the Health-Process-Evidence-based Clinical Practice Guidelines that I have been advocating circa 2002 emphasizing the HEALTH concept of World Health Organization; Process of ROJoson’s Patient Management Process particularly using benefit-risk-cost-availability analysis of options; and of course, evidence-based medicine.